Cardinal Health (NYSE:CAH)‘s stock had its “hold” rating restated by Robert W. Baird in a research report issued on Wednesday. They currently have a $80.00 price target on the stock. Robert W. Baird’s price objective points to a potential upside of 10.12% from the company’s current price.

A number of other brokerages have also weighed in on CAH. Evercore ISI started coverage on Cardinal Health in a research report on Thursday, January 4th. They set an “in-line” rating and a $67.00 price objective on the stock. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. Cowen upgraded Cardinal Health to a “buy” rating and set a $74.00 price objective on the stock in a research report on Tuesday, October 10th. Finally, Mizuho set a $70.00 price objective on Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, October 24th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $73.58.

Shares of Cardinal Health (NYSE:CAH) traded up $0.07 on Wednesday, hitting $72.65. The stock had a trading volume of 3,369,972 shares, compared to its average volume of 3,436,318. Cardinal Health has a one year low of $54.66 and a one year high of $84.88. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.52 and a current ratio of 1.06. The company has a market cap of $22,900.00, a price-to-earnings ratio of 21.18, a price-to-earnings-growth ratio of 2.02 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The company had revenue of $32.64 billion for the quarter, compared to analyst estimates of $33.48 billion. During the same quarter last year, the company posted $1.24 EPS. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. equities analysts expect that Cardinal Health will post 5.08 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the business. Steward Partners Investment Advisory LLC acquired a new position in Cardinal Health during the 3rd quarter worth about $102,000. Advisory Services Network LLC lifted its holdings in Cardinal Health by 18.4% during the 2nd quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock worth $136,000 after buying an additional 270 shares during the period. Sun Life Financial INC lifted its holdings in Cardinal Health by 16,228.6% during the 2nd quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock worth $178,000 after buying an additional 2,272 shares during the period. First PREMIER Bank acquired a new position in Cardinal Health during the 4th quarter worth about $163,000. Finally, Arete Wealth Advisors LLC acquired a new position in Cardinal Health during the 2nd quarter worth about $224,000. 88.36% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Cardinal Health (CAH) Earns Hold Rating from Robert W. Baird” was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/01/17/cardinal-health-cah-earns-hold-rating-from-robert-w-baird.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.